The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity
Chimeric antigen receptors (CARs) are effective tools for directing T cell killing of tumors, but may cause adverse side effects. Here the authors show that coupling of antigen-recognition and CD3-binding in a modular format induces more efficient anti-tumour responses but reduced toxicity when comp...
Main Authors: | Christopher W. Helsen, Joanne A. Hammill, Vivian W. C. Lau, Kenneth A. Mwawasi, Arya Afsahi, Ksenia Bezverbnaya, Lisa Newhook, Danielle L. Hayes, Craig Aarts, Bojana Bojovic, Galina F. Denisova, Jacek M. Kwiecien, Ian Brain, Heather Derocher, Katy Milne, Brad H. Nelson, Jonathan L. Bramson |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-018-05395-y |
Similar Items
-
94 The T cell antigen coupler (TAC) redirects T cell oncolysis while limiting tonic signaling to create a safer engineered T cell product with a higher threshold for activation
by: Vivian Lau, et al.
Published: (2020-11-01) -
A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity
by: Joanne A. Hammill, et al.
Published: (2020-06-01) -
Chimeric antigen receptorâengineered T cells as oncolytic virus carriers
by: Heather VanSeggelen, et al.
Published: (2015-01-01) -
Molecular genetic analysis of the neurokinin B (TAC3) and neurokinin B receptor (TAC3) genes as candidates for pre-eclampsia
by: Carelse Tofa, Kashefa
Published: (2012) -
Co-Opting Host Receptors for Targeted Delivery of Bioconjugates—From Drugs to Bugs
by: Kristen M. Tummillo, et al.
Published: (2021-03-01)